Pfizer and AstraZeneca vaccines approved for booster scheme
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
The announcement comes after its sales soared by over 50 percent in last quarter after it made more than £780million worth of vaccine sales.
But now for the first time, AstraZeneca has said that it will seek to pofit from sales of the jab in order to fund an antibody treatment that the company will work on.
They have reportedly said that they will start making only a small profit from the vaccine, and that profit will be diverted to fund the work on the new Covid wonderdrug.
It comes after AstraZeneca reported this morning that their sales went up 28 percent to just over $25billion (£18.7billion).
But the company had not increased its profits guidance for the year, which meant the share prices were two percent lower.
The pharmaceutical giant was keen to explain that now, only modest profits will be made from the vaccine.
This is a breaking story. More to follow.
Source: Read Full Article
